Thermo Fisher Scientific Inc (TMO)
595.30
-1.85
(-0.31%)
USD |
NYSE |
May 17, 16:00
595.32
+0.02
(+0.00%)
After-Hours: 20:00
Thermo Fisher Scientific Cash from Financing (Quarterly): -1.821B for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.821B |
| December 31, 2023 | -1.428B |
| September 30, 2023 | 1.855B |
| June 30, 2023 | -1.456B |
| March 31, 2023 | -2.593B |
| December 31, 2022 | 2.391B |
| September 30, 2022 | -151.00M |
| June 30, 2022 | -1.905B |
| March 31, 2022 | -3.145B |
| December 31, 2021 | 8.467B |
| September 30, 2021 | 3.04B |
| June 30, 2021 | -76.00M |
| March 31, 2021 | -4.85B |
| December 31, 2020 | -49.00M |
| September 30, 2020 | -791.00M |
| June 30, 2020 | 1.18B |
| March 31, 2020 | 619.00M |
| December 31, 2019 | -514.00M |
| September 30, 2019 | -1.869B |
| June 30, 2019 | 690.00M |
| March 31, 2019 | -1.425B |
| December 31, 2018 | -13.00M |
| September 30, 2018 | -876.00M |
| June 30, 2018 | -1.006B |
| March 31, 2018 | -342.00M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.144B |
| September 30, 2017 | 6.081B |
| June 30, 2017 | -964.00M |
| March 31, 2017 | -119.00M |
| December 31, 2016 | -2.191B |
| September 30, 2016 | 4.721B |
| June 30, 2016 | -913.30M |
| March 31, 2016 | 1.142B |
| December 31, 2015 | -869.90M |
| September 30, 2015 | -817.80M |
| June 30, 2015 | -828.90M |
| March 31, 2015 | -100.40M |
| December 31, 2014 | 89.30M |
| September 30, 2014 | -1.114B |
| June 30, 2014 | -1.814B |
| March 31, 2014 | 7.635B |
| December 31, 2013 | 3.324B |
| September 30, 2013 | -15.60M |
| June 30, 2013 | 29.90M |
| March 31, 2013 | -27.80M |
| December 31, 2012 | -607.40M |
| September 30, 2012 | 558.70M |
| June 30, 2012 | -284.00M |
| March 31, 2012 | -585.00M |
| December 31, 2011 | -446.40M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-4.85B
Minimum
Mar 2021
8.467B
Maximum
Dec 2021
-120.30M
Average
-332.50M
Median
Cash from Financing (Quarterly) Benchmarks
| Fonar Corp | -1.761M |
| XWELL Inc | 0.00 |
| ProPhase Labs Inc | 2.271M |
| Applied DNA Sciences Inc | 3.015M |
| Veracyte Inc | -0.864M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.251B |
| Cash from Investing (Quarterly) | -2.03B |
| Free Cash Flow | 7.56B |
| Free Cash Flow Per Share (Quarterly) | 2.354 |
| Free Cash Flow to Equity (Quarterly) | 213.00M |
| Free Cash Flow to Firm (Quarterly) | 973.15M |
| Free Cash Flow Yield | 3.28% |